Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 4, 2013

ARCA biopharma, Astellas, BioMarin, Immunomedics, Medivation, OncoMed, RXi, Senesco

Phase I
OncoMed begins pancreatic cancer trial . . . read more

RXi to advance CTGF scar treatment . . . read more

Senesco completes third cohort in myeloma trial . . . read more

Phase II
Medivation, Astellas begin breast cancer trial . . . read more

Filings
ARCA IND approved for AF study . . . read more

BioMarin submits Vimizim in Canada . . . read more

Immunomedics ADC gets Orphan status . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters